[LGND] YoY Quarter Result on 30-Jun-2019 [#Q2]

Stock
[LGND] Ligand Pharmaceuticals Incorporated
Announcement Date
08-Aug-2019
Financial Year
2019
Quarter
30-Jun-2019 [#Q2]
Profit Trend
QoQ- -102.16%
YoY- -119.71%
Quarter Report
LGND's Result
LGND's Financial Summary
View:
Show?
Quarter Result
30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 CAGR
Revenue 57,419 84,675 41,420 24,987 90,043 27,995 19,521 19.68%
PBT -636 33,301 28,119 -18,028 95,579 8,300 -9,644 -36.42%
Tax 259 2,576 6,033 -3,609 22,419 2,242 -3,881 -
NP -895 30,725 22,086 -14,419 73,160 6,058 -5,763 -26.67%
Tax Rate - -7.74% -21.46% - -23.46% -27.01% - -
Total Cost 58,314 53,950 19,334 39,406 16,883 21,937 25,284 14.93%
Ratio Analysis
30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 CAGR
NP Margin -1.56 36.29 53.32 -57.71 81.25 21.64 -29.52 -38.72%
Per Share
30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 CAGR
EPS -0.05 1.84 1.38 -0.74 3.45 0.29 -0.28 -24.94%
EPS Diluted -0.05 1.79 1.32 -0.74 2.99 0.26 -0.28 -24.94%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.